<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on September 7, 2026 at 2:48 PM by All in One SEO v5.0.1.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Mon, 07 Sep 2026 07:26:26 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/roivant-and-pulmovant-to-unveil-topline-mosliciguat-results-in-ph-ild/]]></guid>
			<link><![CDATA[https://cgxpwire.com/roivant-and-pulmovant-to-unveil-topline-mosliciguat-results-in-ph-ild/]]></link>
			<title>Roivant and Pulmovant to Unveil Topline Mosliciguat Results in PH-ILD</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 07:26:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/astrazeneca-wins-u-s-approval-for-etcamah-in-breast-cancer/]]></guid>
			<link><![CDATA[https://cgxpwire.com/astrazeneca-wins-u-s-approval-for-etcamah-in-breast-cancer/]]></link>
			<title>AstraZeneca Wins U.S. Approval for ETCAMAH in Breast Cancer</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 06:05:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/novartis-and-ionis-pharmaceuticals-face-setback-in-pelacarsen-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/novartis-and-ionis-pharmaceuticals-face-setback-in-pelacarsen-trial/]]></link>
			<title>Novartis and Ionis Pharmaceuticals Face Setback in Pelacarsen Trial</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:57:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/modular-medical-expands-pivot-pump-access-through-u-s-pbm-contract/]]></guid>
			<link><![CDATA[https://cgxpwire.com/modular-medical-expands-pivot-pump-access-through-u-s-pbm-contract/]]></link>
			<title>Modular Medical Expands Pivot Pump Access Through U.S. PBM Contract</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:32:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biogen-reports-long-term-zorevunersen-data-in-dravet-syndrome/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biogen-reports-long-term-zorevunersen-data-in-dravet-syndrome/]]></link>
			<title>Biogen Reports Long-Term Zorevunersen Data in Dravet Syndrome</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:27:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/argo-biopharma-reports-positive-phase-ii-data-for-bw-20805-in-hae/]]></guid>
			<link><![CDATA[https://cgxpwire.com/argo-biopharma-reports-positive-phase-ii-data-for-bw-20805-in-hae/]]></link>
			<title>Argo Biopharma Reports Positive Phase II Data for BW-20805 in HAE</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:23:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/fda-seeks-input-to-advance-botanical-drug-development/]]></guid>
			<link><![CDATA[https://cgxpwire.com/fda-seeks-input-to-advance-botanical-drug-development/]]></link>
			<title>FDA Seeks Input to Advance Botanical Drug Development</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:20:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/fda-seeks-input-to-advance-botanical-drug-development/]]></guid>
			<link><![CDATA[https://cgxpwire.com/fda-seeks-input-to-advance-botanical-drug-development/]]></link>
			<title>FDA Seeks Input to Advance Botanical Drug Development</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:20:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/evinova-and-lothar-medical-partner-to-modernize-respiratory-trials/]]></guid>
			<link><![CDATA[https://cgxpwire.com/evinova-and-lothar-medical-partner-to-modernize-respiratory-trials/]]></link>
			<title>Evinova and Lothar Medical Partner to Modernize Respiratory Trials</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:19:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/abbvie-completes-10-9-billion-apogee-acquisition/]]></guid>
			<link><![CDATA[https://cgxpwire.com/abbvie-completes-10-9-billion-apogee-acquisition/]]></link>
			<title>AbbVie Completes $10.9 Billion Apogee Acquisition</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:16:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/acepodia-gains-fda-ind-clearance-for-ace723-adc/]]></guid>
			<link><![CDATA[https://cgxpwire.com/acepodia-gains-fda-ind-clearance-for-ace723-adc/]]></link>
			<title>Acepodia Gains FDA IND Clearance for ACE723 ADC</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:13:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/agilent-launches-s540md-slide-scanner-in-the-u-s/]]></guid>
			<link><![CDATA[https://cgxpwire.com/agilent-launches-s540md-slide-scanner-in-the-u-s/]]></link>
			<title>Agilent Launches S540MD Slide Scanner in the U.S.</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 05:08:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/rezubio-advances-rz-520-with-fda-and-nmpa-ind-clearances/]]></guid>
			<link><![CDATA[https://cgxpwire.com/rezubio-advances-rz-520-with-fda-and-nmpa-ind-clearances/]]></link>
			<title>Rezubio Advances RZ-520 with FDA and NMPA IND Clearances</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:59:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/cytek-biosciences-highlights-spectral-flow-cytometry-at-escca/]]></guid>
			<link><![CDATA[https://cgxpwire.com/cytek-biosciences-highlights-spectral-flow-cytometry-at-escca/]]></link>
			<title>Cytek Biosciences Highlights Spectral Flow Cytometry at ESCCA</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:51:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/globus-medical-gains-ce-mark-for-excelsius3d-imaging/]]></guid>
			<link><![CDATA[https://cgxpwire.com/globus-medical-gains-ce-mark-for-excelsius3d-imaging/]]></link>
			<title>Globus Medical Gains CE Mark for Excelsius3D Imaging</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:50:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/persica-strengthens-pp353-case-in-vertebrogenic-back-pain/]]></guid>
			<link><![CDATA[https://cgxpwire.com/persica-strengthens-pp353-case-in-vertebrogenic-back-pain/]]></link>
			<title>Persica Strengthens PP353 Case in Vertebrogenic Back Pain</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:45:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/abbvie-reports-positive-phase-3-etentamig-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/abbvie-reports-positive-phase-3-etentamig-results/]]></link>
			<title>AbbVie Reports Positive Phase 3 Etentamig Results</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:43:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clearmind-advances-cmnd-100-into-phase-iia-trial-for-alcohol-use-disorder/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clearmind-advances-cmnd-100-into-phase-iia-trial-for-alcohol-use-disorder/]]></link>
			<title>Clearmind Advances CMND-100 Into Phase IIa Trial for Alcohol Use Disorder</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:41:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/fda-authorizes-nitenpyram-for-new-world-screwworm/]]></guid>
			<link><![CDATA[https://cgxpwire.com/fda-authorizes-nitenpyram-for-new-world-screwworm/]]></link>
			<title>FDA Authorizes Nitenpyram for New World Screwworm</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:38:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/alcon-launches-unity-m-ophthalmic-microscope-for-enhanced-surgical-precision/]]></guid>
			<link><![CDATA[https://cgxpwire.com/alcon-launches-unity-m-ophthalmic-microscope-for-enhanced-surgical-precision/]]></link>
			<title>Alcon Launches UNITY M Ophthalmic Microscope for Enhanced Surgical Precision</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:38:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/gsk-files-eu-submission-for-lower-carbon-ventolin/]]></guid>
			<link><![CDATA[https://cgxpwire.com/gsk-files-eu-submission-for-lower-carbon-ventolin/]]></link>
			<title>GSK Files EU Submission for Lower-Carbon Ventolin</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:35:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/iqvia-launches-ai-powered-predictive-clinical-development/]]></guid>
			<link><![CDATA[https://cgxpwire.com/iqvia-launches-ai-powered-predictive-clinical-development/]]></link>
			<title>IQVIA Launches AI-Powered Predictive Clinical Development</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:33:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/fda-approves-zanvastro-as-first-alexander-disease-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/fda-approves-zanvastro-as-first-alexander-disease-drug/]]></link>
			<title>FDA Approves Zanvastro as First Alexander Disease Drug</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:32:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/egenesis-reports-kidney-xenotransplantation-clinical-progress/]]></guid>
			<link><![CDATA[https://cgxpwire.com/egenesis-reports-kidney-xenotransplantation-clinical-progress/]]></link>
			<title>eGenesis Reports Kidney Xenotransplantation Clinical Progress</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:29:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/cipla-partners-with-qilu-on-keytruda-biosimilar/]]></guid>
			<link><![CDATA[https://cgxpwire.com/cipla-partners-with-qilu-on-keytruda-biosimilar/]]></link>
			<title>Cipla Partners with Qilu on Keytruda Biosimilar</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:28:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/curia-expands-albuquerque-facility-for-sterile-drug-manufacturing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/curia-expands-albuquerque-facility-for-sterile-drug-manufacturing/]]></link>
			<title>Curia Expands Albuquerque Facility for Sterile Drug Manufacturing</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:23:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/insmed-presents-new-arikayce-data-from-phase-3b-encore/]]></guid>
			<link><![CDATA[https://cgxpwire.com/insmed-presents-new-arikayce-data-from-phase-3b-encore/]]></link>
			<title>Insmed Presents New ARIKAYCE Data From Phase 3b ENCORE</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:10:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/philips-launches-ev14-2v-transducer-for-womens-health/]]></guid>
			<link><![CDATA[https://cgxpwire.com/philips-launches-ev14-2v-transducer-for-womens-health/]]></link>
			<title>Philips Launches eV14-2v Transducer for Women’s Health</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:19:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/kali-therapeutics-wins-fda-clearance-for-kt501-ind/]]></guid>
			<link><![CDATA[https://cgxpwire.com/kali-therapeutics-wins-fda-clearance-for-kt501-ind/]]></link>
			<title>Kali Therapeutics Wins FDA Clearance for KT501 IND</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:35:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/eisai-and-biogen-win-china-approval-for-leqembi-sc/]]></guid>
			<link><![CDATA[https://cgxpwire.com/eisai-and-biogen-win-china-approval-for-leqembi-sc/]]></link>
			<title>Eisai and Biogen Win China Approval for LEQEMBI SC</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:30:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/american-regent-recalls-epinephrine-injection-over-sterility/]]></guid>
			<link><![CDATA[https://cgxpwire.com/american-regent-recalls-epinephrine-injection-over-sterility/]]></link>
			<title>American Regent Recalls Epinephrine Injection Over Sterility</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:15:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/alpha-tau-completes-impact-pancreatic-cancer-enrollment/]]></guid>
			<link><![CDATA[https://cgxpwire.com/alpha-tau-completes-impact-pancreatic-cancer-enrollment/]]></link>
			<title>Alpha Tau Completes IMPACT Pancreatic Cancer Enrollment</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:26:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pulnovo-medical-reports-padn-trial-results-in-nejm/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pulnovo-medical-reports-padn-trial-results-in-nejm/]]></link>
			<title>Pulnovo Medical Reports PADN Trial Results in NEJM</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:26:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/autonomix-medical-presents-nerve-technology-at-cirse-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/autonomix-medical-presents-nerve-technology-at-cirse-2026/]]></link>
			<title>Autonomix Medical Presents Nerve Technology at CIRSE 2026</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:16:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/lundbeck-advances-bexicaserin-research-in-rare-epilepsy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/lundbeck-advances-bexicaserin-research-in-rare-epilepsy/]]></link>
			<title>Lundbeck Advances Bexicaserin Research in Rare Epilepsy</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:13:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/gan-lee-and-menarini-advance-bofanglutide-in-europe/]]></guid>
			<link><![CDATA[https://cgxpwire.com/gan-lee-and-menarini-advance-bofanglutide-in-europe/]]></link>
			<title>Gan &amp; Lee and Menarini Advance Bofanglutide in Europe</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:12:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/armata-advances-phage-therapy-with-new-ar-km-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/armata-advances-phage-therapy-with-new-ar-km-research/]]></link>
			<title>Armata Advances Phage Therapy With New Ar-KM Research</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:11:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/heartvue-ai-and-innolitics-gain-fda-clearance-for-cardiac-mri-ai/]]></guid>
			<link><![CDATA[https://cgxpwire.com/heartvue-ai-and-innolitics-gain-fda-clearance-for-cardiac-mri-ai/]]></link>
			<title>Heartvue.ai and Innolitics Gain FDA Clearance for Cardiac MRI AI</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:11:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/caris-life-sciences-advances-precision-oncology-at-wclc/]]></guid>
			<link><![CDATA[https://cgxpwire.com/caris-life-sciences-advances-precision-oncology-at-wclc/]]></link>
			<title>Caris Life Sciences Advances Precision Oncology at WCLC</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:10:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/akeso-reports-ivonescimab-os-benefit-in-harmoni-2/]]></guid>
			<link><![CDATA[https://cgxpwire.com/akeso-reports-ivonescimab-os-benefit-in-harmoni-2/]]></link>
			<title>Akeso Reports Ivonescimab OS Benefit in HARMONi-2</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:08:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/iba-joins-pfaros-to-advance-pfas-destruction-in-healthcare/]]></guid>
			<link><![CDATA[https://cgxpwire.com/iba-joins-pfaros-to-advance-pfas-destruction-in-healthcare/]]></link>
			<title>IBA Joins PFAROS to Advance PFAS Destruction in Healthcare</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:08:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/insilico-medicine-identifies-alzheimers-targets-using-ai/]]></guid>
			<link><![CDATA[https://cgxpwire.com/insilico-medicine-identifies-alzheimers-targets-using-ai/]]></link>
			<title>Insilico Medicine Identifies Alzheimer’s Targets Using AI</title>
			<pubDate><![CDATA[Sat, 05 Sep 2026 03:09:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/thryv-licenses-new-sgk1-inhibitors-for-neurodegeneration/]]></guid>
			<link><![CDATA[https://cgxpwire.com/thryv-licenses-new-sgk1-inhibitors-for-neurodegeneration/]]></link>
			<title>Thryv Licenses New SGK1 Inhibitors for Neurodegeneration</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 04:09:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/hutchmed-and-gsk-partner-on-kras-egfr-cancer-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/hutchmed-and-gsk-partner-on-kras-egfr-cancer-therapy/]]></link>
			<title>HUTCHMED and GSK Partner on KRAS-EGFR Cancer Therapy</title>
			<pubDate><![CDATA[Fri, 04 Sep 2026 17:07:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/summit-therapeutics-and-akeso-report-ivonescimab-survival-benefit/]]></guid>
			<link><![CDATA[https://cgxpwire.com/summit-therapeutics-and-akeso-report-ivonescimab-survival-benefit/]]></link>
			<title>Summit Therapeutics and Akeso Report Ivonescimab Survival Benefit</title>
			<pubDate><![CDATA[Fri, 04 Sep 2026 06:52:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/gt-medical-technologies-expands-gammatile-center-program/]]></guid>
			<link><![CDATA[https://cgxpwire.com/gt-medical-technologies-expands-gammatile-center-program/]]></link>
			<title>GT Medical Technologies Expands GammaTile Center Program</title>
			<pubDate><![CDATA[Fri, 04 Sep 2026 06:44:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/allergan-aesthetics-reveals-global-layered-beauty-report/]]></guid>
			<link><![CDATA[https://cgxpwire.com/allergan-aesthetics-reveals-global-layered-beauty-report/]]></link>
			<title>Allergan Aesthetics Reveals Global Layered Beauty Report</title>
			<pubDate><![CDATA[Fri, 04 Sep 2026 06:39:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/alkeus-reports-positive-gildeuretinol-results-in-stargardt-disease/]]></guid>
			<link><![CDATA[https://cgxpwire.com/alkeus-reports-positive-gildeuretinol-results-in-stargardt-disease/]]></link>
			<title>Alkeus Reports Positive Gildeuretinol Results in Stargardt Disease</title>
			<pubDate><![CDATA[Fri, 04 Sep 2026 06:18:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/milestone-pharmaceuticals-secures-first-overseas-etripamil-approval/]]></guid>
			<link><![CDATA[https://cgxpwire.com/milestone-pharmaceuticals-secures-first-overseas-etripamil-approval/]]></link>
			<title>Milestone Pharmaceuticals Secures First Overseas Etripamil Approval</title>
			<pubDate><![CDATA[Fri, 04 Sep 2026 06:18:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pendopharm-and-ascendis-pharma-gain-canada-reimbursement-recommendation-for-yorvipath/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pendopharm-and-ascendis-pharma-gain-canada-reimbursement-recommendation-for-yorvipath/]]></link>
			<title>Pendopharm and Ascendis Pharma Gain Canada Reimbursement Recommendation for Yorvipath</title>
			<pubDate><![CDATA[Fri, 04 Sep 2026 06:06:51 +0000]]></pubDate>
		</item>
				</channel>
</rss>
